Gene: ETNPPL
Official Full Name: ethanolamine-phosphate phospho-lyaseprovided by HGNC
Gene Summary: Enables ethanolamine-phosphate phospho-lyase activity. Predicted to act upstream of or within several processes, including cellular response to glucocorticoid stimulus; ceramide phosphoethanolamine catabolic process; and phospholipid transfer to membrane. Predicted to be located in mitochondrial matrix. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17870 | ETNPPL Knockout cell line (HeLa) | Human | ETNPPL | 1:3~1:6 | Negative | Online Inquiry |
ETNPPL Gene Knockout Cell Lines are genetically engineered cellular models specifically designed to study the functions and regulatory mechanisms of the ETNPPL gene, which plays a significant role in various metabolic pathways within cellular biology. By employing CRISPR-Cas9 gene editing technology, these cell lines provide a reliable platform for creating precise disruptions in the ETNPPL gene, allowing researchers to explore the downstream effects of gene loss on cellular functions, phenotypes, and signaling pathways.
The key functions of ETNPPL Gene Knockout Cell Lines include enabling the dissection of metabolic processes, examining gene interactions, and understanding the impact of gene disruption on cell viability and proliferation. This is particularly valuable in the context of metabolic disorders and provides a crucial tool for elucidating the role of ETNPPL in human health and disease. These cell lines can be utilized in drug discovery and functional assays, making them indispensable for both basic research and translational applications.
The scientific importance of these knockout cell lines resides in their ability to provide insights into gene function that cannot be gleaned from conventional models. They enable the identification of potential therapeutic targets and the development of innovative treatments for diseases linked to ETNPPL dysregulation. Unlike other models, such as siRNA or shRNA, which offer transient gene silencing, our knockout cell lines facilitate stable and permanent gene disruptions, leading to more consistent and reproducible results.
This product stands out due to its high specificity, robust performance, and the ability to generate a wide range of physiological models relevant to human diseases. Researchers and clinicians will find immense value in these cell lines, as they provide a consistent foundation for generating hypotheses, testing clinical theories, and ultimately contributing to advancements in precision medicine.
With our commitment to high-quality biological products and a track record of excellence in genetic engineering, our company stands at the forefront of supporting researchers and clinicians with innovative tools like the ETNPPL Gene Knockout Cell Lines, driving breakthroughs in life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.